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Oxygen free radicals generated by xanthine oxidase are able to depolymerize hyaluronic acid in the presence 
of ferritin-bound iron. This suggests that ferritin can catalyse the Haber-Weiss reaction, leading to the for- 
mation of highly damaging hydroxyl radicals. 
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1. INTRODUCTION 
It has long been known that oxygen is toxic to 
aerobic cells when supplied in concentrations 
above the normal. Some biochemical mechanisms 
that have been suggested as explanations for this 
oxygen toxicity include participation of the 
superoxide radical (review [l]). This radical is not 
very reactive in itself, at least not in aqueous solu- 
tions (see discussion in [2]), and it has therefore 
been theorized that it interacts with hydrogen 
peroxide to form the highly reactive hydroxyl 
radical (the Haber-Weiss reaction); this reaction 
requires a catalyst such as copper or iron ions 
(Fenton-type catalysis; review [2]). Authors in [3] 
have proposed that phosphate-bound ferric iron is 
the physiological catalyst. Here we demonstrate 
that ferritin-bound iron is able to catalyse the for- 
mation of hydroxyl radicals from the superoxide 
generated by xanthine oxidase. 
2. MATERIALS AND METHODS 
The viscosity measurements were carried out in 
an ijbbelohde viscometer (unpublished). Briefly, 
the reaction mixture contained 0.5 mg/ml 
hyaluronic acid (Healon@, ii& 3 x 106, Pharmacia 
AB, Uppsala), 0.2 mM hypoxanthine and 
1.7 mUnits/ml xanthine oxidase in a 0.05 M 
Iron Chelating agent Hyaluronic acid degradation 
phosphate buffer (pH 7.4). The xanthine oxidase 
was prepared from bovine milk as in [4]. Only one 
protein peak appeared on a Sephacryl G-200 
chromatogram. One unit converts l.Opmol xan- 
thine to uric acid per min at 25°C. The iron con- 
tent of the reaction mixture was O.O6rg/ml, as 
determined by atomic absorption; 0.04 pg/ml was 
derived from the hyaluronic acid preparation, only 
half of which could be removed by Chelex treat- 
ment and then at the expense of a considerable 
decrease in viscosity. The reagents were therefore 
not routinely treated with Chelex to remove iron. 
Ferritin type I and apoferritin from horse spleen 
were purchased from Sigma (St. Louis, MO). The 
iron content of the ferritin was 22% and that of 
apoferritin O.Ol%, as determined by atomic ab- 
sorption. Ferritin and apoferritin were further 
purified by desalting on a molecular sieve column 
(PD-10, Pharmacia AB, Uppsala), either untreated 
or preincubated with 10 mM desferrioxamine 
(CIBA-Geigy AG, Basel) or 25 mM EDTA to 
remove loosely bound Fe ions. 
The reduction in specific viscosity, nsp (Fig. l), of 
the reaction mixture was a logarithmic function of 
time, i.e., it followed first-order reaction kinetics 
[3] at least for an experimental time, t, of up to 
60 min. The nsp was calculated as A/B - 1, where 
A is the flow time for the reaction mixture and B 
is the flow time for the buffer; after a prolonged 
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Fig.1. The decrease in hyaluronic acid viscosity. The 
graph illustrates an experiment in which 50pM EDTA 
was added. The ordinate shows the flow time through 
the capillary viscometer. Enzyme was added at 0 min. 
Each point represents one measurement. The broken line 
indicates the flow time for the buffer. 
experimental time, A would eventually reach the 
value of B. The rate constant, k, used to express 
the reaction velocity was calculated from a plot of 
In (n,,) vs t, which has a slope of - k according to 
the first-order reaction rate equation: 
In@,& - ln(n,,)o = - kt. The coefficient of varia- 
tion between multiplicate experiments was 10% or 
less. 
3. RESULTS 
Oxygen free radicals produced by xanthine ox- 
idase in the absence of EDTA and ferritin caused 
only a very small decrease in the viscosity of 
hyaluronic acid. Addition of ferritin resulted in a 
decrease in viscosity, the rate of which was depen- 
dent upon the ferritin concentration. The effect 
observed was apparently not due to unbound iron 
ions in the ferritin preparation, as desalting of fer- 
ritin, either untreated or preincubated with the 
iron chelator EDTA or desferrioxamine, did not 
result in any significant change in the reaction rate 
(not shown). Apoferritin was considerably less po- 
tent than ferritin at the same protein concentra- 
tion, although the minute amounts of iron present 
in the apoferritin had a comparatively high specific 
activity. Both the apoferritin and ferritin effects 
were iron-dependent, since they were abolished by 
desferrioxamine, which is known to form an iron 
complex which is unable to catalyse the Haber- 
Weiss reaction [5]. Furthermore, addition of FeC13 
to the reaction mixture did not influence the reac- 
tion rate, indicating that apoferritin did not act 
simply by forming an iron complex analogous to 
that of EDTA. The apoferritin preparation con- 
tained a catalyst which could be removed by 
desalting chromatography. 
Addition of EDTA to the reaction mixture 
resulted in a marked increase in the reaction rate 
due to the formation of a highly active catalytic 
complex between EDTA and traces of iron in the 
buffer. Addition of EDTA to a ferritin-containing 
reaction mixture caused an even more pronounced 
increase, although it may not be correct to at- 
tribute this to a ferritin-EDTA complex, since the 
iron contamination could not be removed from the 
other reagents. 
4. DISCUSSION 
The ability of protein-bound iron to catalyse the 
Haber-Weiss reaction in biological systems has 
been a matter of controversy. Transferrin [6-81 
and lactoferrin [9,10] have been found to catalyse 
hydroxyl radical production induced by NADPH 
oxidase and xanthine oxidase. On the other hand, 
in [II] it was shown that the iron-containing pro- 
teins horseradish peroxidase, myeloperoxidase and 
ferritin did not catalyse the Haber-Weiss reaction; 
in [ll] it was reported that lactoferrin was only a 
weak catalyst in the absence of EDTA, and in [ 131, 
in ESR studies, no hydroxyl radical formation 
from Hz02 was found in the presence of ferritin or 
transferrin. Authors in [3] and [14] presented 
evidence that only ‘free’ (not protein-bound) iron 
and, especially, iron chelated to molecules such as 
phosphate, ADP or ATP will function as 
physiological iron catalysts. 
This study suggests that ferritin is able to 
catalyse the Haber-Weiss reaction leading to 
hydroxyl radical-dependent 115,161 depolymeriza- 
tion of hyaluronic acid. Our main argument in 
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Table 1 
Effect of additives on the xanthine-oxidase-induced epolymerization of hyaluronic acid 
Additive Apoferritin/ Iron* 
ferritin @g/ml) 
kg/ml) 
None 0 0 
FeCI3, SpM 0 0.3 
Ferritin 216 48 
Ferritinb 5 1.1 
12 2.6 
60 13 
100 22 
300 66 
Ferritin + Desf, 0.1 mM 216 48 
+ Desf, 1 mM 216 48 
Ferritinb + Desf, 0.05 mM 60 13 
+ Desf, 0.1 mM 60 13 
Apoferritin 200 0.02 
400 0.04 
Apoferritinb 50 0.005 
150 0.015 
Apoferritin + Desf, 0.1 mM 200 0.02 
Apoferritinb + Desf, 0.05 mM 150 0.015 
Apoferritin + FeCl3, 5 PM 200 0.35 
EDTA, 50pM 0 0 
Ferritin + EDTA, 50pM 60 13 
a In addition to O.O6pg/ml basically present in the reaction mixture 
b Desalted by gel chromatography 
Desf, desferrioxamine 
Rate constant 
(h-l) 
0.05 
0.05 
1.12 
0.02 
0.15 
0.56 
1.10 
1.20 
0.10 
0.00 
0.21 
0.13 
0.52 
0.49 
0.04 
0.29 
0.00 
0.02 
0.59 
2.77 
7.5 
favour of the idea that the catalyst is ferritin- 
bound iron, and not contaminating iron ions, is 
that EDTA was not required for the hyaluronic 
acid depolymerization. This is in contrast with the 
situation where iron added in the form of FeCls or 
ferric iron contaminated the buffer. Furthermore, 
attempts to remove unbound iron by chelation and 
desalting chromatography did not indicate the 
presence of unbound iron. 
Early studies showed that ferritin iron was 
reduced in the xanthine oxidase reaction and 
removed from the protein. Ferrous iron reacts with 
dissolved molecular oxygen, leading to the forma- 
tion of hydroxyl radicals. Later studies have 
revealed, however [17], that only a very small 
amount of the total ferritin iron is released, mak- 
ing this mechanism of radical generation less 
likely. 
Authors in [18] discussed a mechanism of 
hydroxyl radical formation by ferritin which may 
be of relevance to our observations. Ferritin- 
bound Fe(II1) is first reduced to Fe(I1) by a reduc- 
tant, e.g., superoxide, and the following reactions 
then lead to hydroxyl radical formation: 
Fe(I1) + 02 = Fe(I1). . . OZ. . . Fe(I1) = 
Fe(III)-0-0-Fe(II1) 
Fe(III)-0-0-Fe(III) + Fe(D) + Hz0 = 
3Fe(III)-OH + OH’ 
Note that the iron is trapped in the protein dur- 
ing the entire reaction. This reaction scheme is 
compatible with the results in [19], where it was 
demonstrated that only iron chelates with at least 
one coordination site open to water will catalyse 
29 
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the Haber-Weiss reaction. The ferritin molecule is 
composed of a protein shell, 2.7 nm thick, cover- 
ing a 7.5 nm central cavity in which the iron is en- 
capsulated; in the protein shell there are 6 chan- 
nels, 1.0 nm wide, through which the iron is 
transported [20]. It is possible that the superoxide 
and hydroxyl radicals are also transported in these 
channels, thereby avoiding reactions with the pro- 
tein shell. 
Ferritin-bound iron is apparently a far less effec- 
tive catalyst than iron complexed to EDTA, which 
may be partly explained by a loss of hydroxyl 
radicals that have reacted with the protein shell 
soon after their formation. However, as pointed 
out in [3], the iron-EDTA complex is an artifact 
of no physiological relevance, and the 
physiological iron chelator is most likely 
phosphate or phosphate esters such as ADP or 
ATP. Despite the use of a phosphate buffer in our 
experiments, we found only a very low reaction 
rate after addition of FeC13. This was apparently 
due to precipitation of Fe3+ by phosphate [19], 
which is prevented by EDTA. 
The physiological importance of the catalytic 
function of ferritin is unknown. The amounts of 
ferritin in normal serum (up to 0.1 pg/ml) and 
tissues (up to 5 pg/ml) [18] may be too low to be 
significant. However, in pathological conditions, 
the serum ferritin level may reach 12 pg/ml [ 181, 
and in rheumatoid arthritis, a disease in which 
iron-catalysed hydroxyl radical formation might 
possibly influence the course of the disease [21], 
the synovial fluid contains ferritin in concentra- 
tions which correlate closely with other indices of 
intra-articular disease activity [22]. In addition, in 
[23], from experiments using ferritin in concentra- 
tions comparable to ours, it was proposed that 
ferritin-stimulated lipid peroxidation may be of 
significance in inflammation-induced tissue 
damage. 
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